Literature DB >> 3987710

The effect of age and body size on the urinary excretion of C-peptide from birth to 14 years of age.

G Gács, P Jakabfi, L Zubovich.   

Abstract

The daily excretion of C-peptide in the urine was measured in 105 healthy infants and children from birth to 14 years of age. For technical reasons no studies were performed from 1-3 years of age. The excretion of C-peptide showed a close positive correlation with age and weight. The relationship with weight was already apparent in the 1st days of life. The C-peptide/weight and the C-peptide/creatinine ratios were constant throughout most of childhood with the exception of the age range of 1 month-1 year when the C-peptide/creatinine was significantly higher. In obese children the C-peptide/weight and C-peptide/creatinine ratios were similar to those found in children with normal weight. In growth hormone deficiency these ratios were low and increased during the 1st week of growth hormone therapy. It is concluded that urinary C-peptide is a reliable indicator of integrated insulin production and gives new information about insulin secretion in various conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987710     DOI: 10.1007/bf00442133

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Islet cell function and glucose homeostasis in hypopituitary dwarfism: synergism between growth hormone and cortisone.

Authors:  L E Underwood; J L Van den Brande; G J Antony; S J Voina; J J Van Wyk
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

2.  Serum-insulin levels in children during glucose tolerance tests.

Authors:  D B Grant
Journal:  Acta Paediatr Scand       Date:  1968-07

3.  Fasting serum C-peptide immunoreactivity in normal children.

Authors:  D Haumont; H Dorchy
Journal:  Acta Paediatr Belg       Date:  1978 Jul-Sep

4.  Age-adjusted analysis of insulin responses during normal and abnormal glucose tolerance tests in children and adolescents.

Authors:  A L Rosenbloom; L Wheeler; R Bianchi; F T Chin; C M Tiwary; A Grgic
Journal:  Diabetes       Date:  1975-09       Impact factor: 9.461

5.  Serum insulin values during oral glucose tolerance test in various age groups.

Authors:  E Kerpel-Fronius; G Gács
Journal:  Acta Paediatr Acad Sci Hung       Date:  1975

6.  Influence of growth hormone on insulin secretion. Studies of growth-hormone deficient subjects.

Authors:  T J Merimee; J A Burgess; D Rabinowitz
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

7.  Insulin and free fatty acid levels during oral glucose tolerance tests and their relation to age in 70 healthy children.

Authors:  H Lestradet; I Deschamps; B Giron
Journal:  Diabetes       Date:  1976-06       Impact factor: 9.461

8.  Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels.

Authors:  R Rossell; R Gomis; R Casamitjana; R Segura; E Vilardell; F Rivera
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

9.  Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids.

Authors:  B J Hoogwerf; F C Goetz
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

10.  Kinetics of human C-peptide in man.

Authors:  O K Faber; H Kehlet; S Madsbad; C Binder
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

View more
  2 in total

1.  Exploring C-peptide loss in type 1 diabetes using growth curve analysis.

Authors:  Rachel E J Besser; Johnny Ludvigsson; Peter C Hindmarsh; Tim J Cole
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

2.  Performance of modified Igls criteria to evaluate islet autograft function after total pancreatectomy with islet autotransplantation - a retrospective study.

Authors:  Kendall R McEachron; Yi Yang; James S Hodges; Gregory J Beilman; Varvara A Kirchner; Timothy L Pruett; Srinath Chinnakotla; Bernhard J Hering; Melena D Bellin
Journal:  Transpl Int       Date:  2020-10-27       Impact factor: 3.782

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.